Antimetabolites: Clinical Trials

6 trials of Antimetabolites, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 active not recruiting, 1 terminated. 3 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Unknown 1
Phase 32Active not recruiting 1, Completed 1
Phase 11Unknown 1

Follow Antimetabolites: new trials by email Literature Review of Antimetabolites trials Research Report on Antimetabolites

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
"Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy"
Methotrexate - Proliferative Vitreoretinopathy
Phase 1 / Phase 2UnknownUniversity of Health Sciences Lahore1202024-03-012024-03-01
Evaluation of the Impact of Reduced Immunosuppression
antimetabolite - Graft Vs Host Disease
CompletedMethodist Health System1002021-10-192026-03-23
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab, epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab - Breast Cancer, Triple Negative Breast Neoplasms
Phase 3Active not recruitingLund University Hospital3252019-12-202025-09-12
Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos
Fluorouracil, Lederfolin, Oxaliplatin - Liver Cancer, Pancreatic Cancer
UnknownUniversity of Pisa1202018-06-012018-09-12
Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma
Standard Guarded Trabeculectomy, Mitomycin C, Bevacizumab - Glaucoma
Phase 2 / Phase 3CompletedAthens Vision Eye Institute402014-01-012016-09-15
Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia
Clofarabine, Cytarabine - Acute Myeloid Leukemia
Phase 2TerminatedUniversity of Pittsburgh22013-10-012016-08-02

Conditions studied

Biliary Tract Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Glaucoma (1)  ·  Graft vs Host Disease (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Liver Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Pathologic Complete Response (1)  ·  Retinal Detachment (1)  ·  Stomach Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Vitreoretinopathy, Proliferative (1)

Sponsors

Athens Vision Eye Institute (1)  ·  Lund University Hospital (1)  ·  Methodist Health System (1)  ·  University of Health Sciences Lahore (1)  ·  University of Pisa (1)  ·  University of Pittsburgh (1)

Countries

United States (2)  ·  Denmark (1)  ·  Italy (1)  ·  Pakistan (1)  ·  Sweden (1)

Top investigators

Ahmad Z Jamil, FCPS,FRCS (1)  ·  Gerassimos Kopsinis, M.D., Ph.D. (1)  ·  Jessica Crotty, PharmD (1)  ·  Luca Morelli, Prof (1)  ·  Michael Boyiadzis, M.D., M.H.Sc (1)  ·  Niklas Loman, MD, PhD (1)

Results publications

PMID 30451176, PMID 32183229, PMID 34336257, PMID 34439284, PMID 34462712